Home    About Us    Medic-All    Bio B2B    Hot Topic     Expo     Login | Join Now          

CHAP™

CHAP™

Cross-Linked Hyaluronic Acid Platform

Request for Collaboration
Overview
CHAP™ is a self-owned technology of SciVision Biotech Inc. which provides the unique viscoelasticity of HYADERMIS™ Facial Dermal Implant series and HYAJOINT Plus™ Synovial Fluid Supplement. CHAP™ gel with water-retention characteristic, acts as a kind of natural sponge. 
It creates volume in the tissue, lubricates, and transports nutrients to and from cells.
Application
This CHAP™ gel is stabilized to prolong the duration and retain the high biocompatibility. The unique CHAP™ technology has been used to produce a wide range of products to achieve facial beauty enhancement, body shaping as well as medical healthcare.
People who like this also like
  • Preimplantation Genetic DiagnosisPreimplantation Genetic Diagnosis
  • SB04SB04
  • Broad-spectrum therapeutic antibody against novel carbohydrate antigen (CHO-A04)Broad-spectrum therapeutic antibody against novel carbohydrate antigen (CHO-A04)
  • CRAM ServicesCRAM Services
  • SB01SB01
  • PHN014 (Acute ischemia stroke)PHN014 (Acute ischemia stroke)
  • LT3001LT3001
  • Homogeneous antibody drugs (CHO-H01, H02, H03)Homogeneous antibody drugs (CHO-H01, H02, H03)
  • SNP-630SNP-630
  • low-alcohol formulation (iLEF) platformlow-alcohol formulation (iLEF) platform